Comparison of Safety and Efficacy of Rosuvastatin (10 Mg) and Atorvastatin (20 Mg) in Cases of Dyslipidaemia Over Six Weeks of Treatment

Journal of Evidence Based Medicine and Healthcare
doi 10.18410/jebmh/2016/476
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Level Up Business Center

Related search

Comparison of Effects of Rosuvastatin (10 Mg) Versus Atorvastatin (40 Mg) on Rho Kinase Activity in Caucasian Men With a Previous Atherosclerotic Event

American Journal of Cardiology
Cardiovascular MedicineCardiology
2009English

Comparison of 4 Mg Versus 20 Mg Intravitreal Triamcinolone Acetonide Injections

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2008English

Comparing the Safety and Efficacy of Rosuvastatin and Atorvastatin in Patients With Coronary Heart Diseases

Journal of Evidence Based Medicine and Healthcare
2019English

Efficacy and Safety of Ezetimibe Added to Atorvastatin Versus Atorvastatin Uptitration or Switching to Rosuvastatin in Patients With Primary Hypercholesterolemia

American Journal of Cardiology
Cardiovascular MedicineCardiology
2013English

Journal Review: Efficacy of a Combined Oral Contraceptive Containing 0.030 Mg Ethinylestradiol/2 Mg Dienogest for the Treatment of Papulopustular Acne in Comparison With Placebo and 0.035 Mg Ethinylestradiol/2 Mg Cyproterone Acetate

Journal of Family Planning and Reproductive Health Care
2009English

Comparison of Efficacy and Safety of Atorvastatin 5% Lotion and Betamethasone 0.1% Lotion in the Treatment of Scalp Seborrheic Dermatitis

Clinical, Cosmetic and Investigational Dermatology
Dermatology
2019English

Efficacy of Pethidine 0.1 and 0.2 Mg/Kg Body Weight as an Adjuvant of Intrathecal Bupivacaine 0.5% 10 Mg in Preventing Shivering

Journal of thee Medical Sciences (Berkala Ilmu Kedokteran)
2013English

Clinical Efficacy and Safety of Monthly Oral Ibandronate 100 Mg Versus Monthly Intravenous Ibandronate 1 Mg in Japanese Patients With Primary Osteoporosis

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2015English

Erratum To: Efficacy and Safety of Olmesartan Medoxomil 40 Mg/Hydrochlorothiazide 12.5 Mg Combination Therapy Versus Olmesartan Medoxomil 40 Mg Monotherapy in Patients With Moderate to Severe Hypertension

Clinical Drug Investigation
MedicinePharmacology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy